Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise

• Status: Completed
• Trial end date: 2008-05-01

Summary

• Comparison of the plasma PK after single use of 100 mg ketoprofen from Diractin®. 50 mg applied on 2 major joints to

• 400 mg ketoprofen from Diractin® (100 mg applied to 4 joints - overexposure)

• 100 mg and 400 mg ketoprofen from Diractin® used concomitant with heat application

• 100 mg and 400 mg ketoprofen from Diractin® used concomitant with moderate exercise

• Phase: Phase 1

Details

• Lead Sponsor: IDEA AG
• Treatments: Ketoprofen